Endocrine and Targeted Therapy for Hormone-Receptor-Positive, HER2-Negative Advanced Breast Cancer: Insights to Sequencing Treatment and Overcoming Resistance Based on Clinical Trials

Background: Advanced hormone-receptor positive HER2 negative breast cancer is a common and a very heterogeneous disease. Hormone therapy is the main first line treatment of choice, given alone or in combination with other agents that have shown to improve patient outcomes, Nevertheless, treatment re...

Descripción completa

Detalles Bibliográficos
Autores principales: El Sayed, Rola, El Jamal, Lara, El Iskandarani, Sarah, Kort, Jeries, Abdel Salam, Mahmoud, Assi, Hazem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6597942/
https://www.ncbi.nlm.nih.gov/pubmed/31281796
http://dx.doi.org/10.3389/fonc.2019.00510

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6597942/
https://www.ncbi.nlm.nih.gov/pubmed/31281796
http://dx.doi.org/10.3389/fonc.2019.00510

Ejemplares similares